Justification for Change
Possession, Use, and Transfer of Select Agents and Toxins (42 CFR Part 73)
(OMB Control No. 0920-0576) Expiration 1/31/2024
Non-substantive Change Request
Centers for Disease Control and Prevention
Office of Public Health Preparedness and Response
Division of Select Agents and Toxins
Lori Bane
(404) 718-2006
(404) 718-2097 FAX
July 1, 2021
Nonmaterial/non-substantive change to an OMB approved information collection for Possession, Use, and Transfer of Select Agents and Toxins (42 CFR Part 73) (OMB Control No. 0920-0576) Expiration 1/31/2024
Justification for the Change - A nonmaterial/non-substantive can be explained in table format as shown below:
| Form | Current Item | Requested Change | Justification | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 | BSL3Ag | ABSL3Ag | Updated to reflect the changes in the recently published 6th edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL). | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Section 6B, Question 6 | Access to the laboratory is through two self-closing doors. | Access to the laboratory is through two consecutive, self-closing doors. | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Attachment C, Question 10 | Describe animal housing for each species, including whether cages provide primary containment and a brief description (e.g. cage or cage rack is HEPA filtered, active or passive ventilation of the cages, non-containment caging housed within inward flow ventilated enclosure). | Describe animal housing for each species, including whether cages provide primary containment and a brief description (e.g. cage or cage rack is HEPA filtered, active or passive ventilation of the cages, non-containment caging housed within inward flow ventilated enclosure). For active ventilation caging, indicate whether or not the system is equipped to indicate operational malfunctions. 
 | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Attachment F, BSL3 Ag, Question 1 (part 2) | For materials which are temperature sensitive, a gas sterilizer, pass-through liquid dunk tank, or a cold gas decontamination chamber are provided. 
 | For materials and equipment that cannot be decontaminated in the autoclave, a pass-through dunk tank, fumigation chamber, or equivalent decontamination method is available. | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Attachment F, BSL3 Ag, Question 6 | There is HEPA filtration of all supply and exhaust air to and from the containment space. 
 | There are two HEPA filters installed in series prior to air being exhausted from the containment space. Supply air passes through ductwork with a HEPA filter and/or fast acting bioseal (i.e., bubble tight) damper that fails in the closed position. | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Attachment F, BSL3 Ag, Question 7a | Personnel ingress and egress only through a series of rooms which includes a ventilated vestibule. 
 | Entrance into the facility is through an interlocking double door vestibule that separates containment areas from non-containment areas. | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Attachment F, BSL3 Ag, Question 7c | Doors that define a containment boundary have compressible or inflatable gaskets, with airtight hinges and latch/knob areas. 
 | Doors that define a containment boundary are sealed and verified airtight through pressure decay testing. | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Attachment F, BSL3 Ag, Question 8 | A second shower is required at the facility access control point before donning street clothing. 
 | A second shower is required at the facility access control point before donning street clothing. If no, describe the alternate strategies used to satisfy the BMBL 6th edition. | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
| APHIS/CDC Form 1: Registration for Possession, Use, and Transfer of Select Agents and Toxins 
 Attachment F, BSL3 Ag, Question 9 | Humane restraining devices are provided in large animal rooms. 
 | Remove question | Updated to reflect the changes in the recently published 6th edition of BMBL. | 
Mini Supporting Statement
Justification for Change
This is a request for nonmaterial/non-substantive change made to Form 1 is to reflect the changes in the recently published 6th edition of Biosafety in Microbiological and Biomedical Laboratories.
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document | 
| Author | Jacob, Cara J. (CDC/DDPHSIS/CPR/DSAT) | 
| File Modified | 0000-00-00 | 
| File Created | 2021-07-08 |